Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MEDSA HOLDING AS
AS
Active
Org 930463221
Nordseterveien 16C, 1176 Oslo
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-16% vs 2023
Equity ratio
54.1%
Financial strength
Net profit 2024
NOK 878K
+66% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -15K
-16%
Net profit
NOK 878K
+66%
Total assets
NOK 756K
+72%
Equity
NOK 409K
+1223%
Employees
0
—
Company information
Legal name
MEDSA HOLDING AS
Org number
930463221
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. desember 2022
Share capital
NOK 90 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Handel, import og eksport av varer, konsulentvirksomhet, investeringer i aksjer og eiendom, samt deltagelse i andre selskaper med lignende virksomhet.
Contact
Address
Nordseterveien 16C, 1176 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
0
0
Staff expenses
−0
−0
−0
EBITDA
0
−13
−15
Depreciation & amort.
−0
−0
−0
EBIT
0
−13
−15
Net financials
0
690
893
Profit before tax
0
677
878
Tax
−0
148
−0
Net profit
0
529
878
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
81
440
756
Equity
24
31
409
Long-term debt
0
0
0
Short-term debt
57
409
347
Total debt
57
409
347
Financial ratios
5-year trend
EBITDA margin
-1531500.0%
This company
15.8%
Market median
-9693138% vs market
2022
2024
Equity ratio
54.1%
This company
38.2%
Market median
+42% vs market
2022
2024
Return on equity
214.7%
This company
18.4%
Market median
+1067% vs market
2022
2024
Net profit margin
87798200.0%
This company
8.1%
Market median
+1083928295% vs market
2022
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-11-22 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SA
Satish Arora
Board of Directors
2022
GR
Gitanjali Rampal
Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
MEDSA HOLDING AS
(this company)
S ARORA AS
PRO-TEK AS
Board network connections
Board members of MEDSA HOLDING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Satish Arora
Board of Directors
0 companies
Gitanjali Rampal
Chairman
0 companies